Oncolytic Viruses: Programmable Tumour Hunters
Journal:
Current Gene Therapy
Volume:
2
Page:
243-254
Author(s):
J. C. Bell, K. A. Garson, B. D. Lichty and F. D. Stojdl
Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Journal:
Current Gene Therapy
Volume:
2
Page:
255-271
Author(s):
Karsten Brand
Scintigraphic Imaging of Inflammatory Processes
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
63-75
Author(s):
Huub J.J.M. Rennen, Otto C. Boerman, Wim J.G. Oyen and Frans H.M. Corstens
Subject Index To Volume 1
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
105-105
Author(s):
Science Publishers Bentham and Bentham Science Publishers
Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
77-86
Author(s):
D. L. Crowe
Phosphofructokinase Deficiency Past, Present and Future
Journal:
Current Molecular Medicine
Volume:
2
Page:
197-212
Author(s):
Hiromu Nakajima, Nina Raben, Tomoya Hamaguchi and Tomoyuki Yamasaki
Protein Factors Mediating Selenoprotein Synthesis
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
143-151
Author(s):
Alain Lescure, Delphine Fagegaltier, Philippe Carbon and Alain Krol
Subject Index To Volume 7
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
85-97
Author(s):
Science Publishers Bentham
The Ca2+-Activated K+ Channel of Intermediate Conductance:A Molecular Target for Novel Treatments?
Journal:
Current Drug Targets
Volume:
2
Page:
401-422
Author(s):
B. S. Jensen, D. Strobaek, S.-P. Olesen and P. Christophersen
Non-Hodgkins Lymphoma: Review of Conventional Treatments
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
279-291
Author(s):
P. Multani, C.A. White and A. Grillo-Lopez